Sandra M. Swain's most recent trade in Immunome Inc was a trade of 18,864 Director Stock Option (right to buy) done . Disclosure was reported to the exchange on June 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunome Inc | Sandra M. Swain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 18,864 | 18,864 | - | - | Director Stock Option (right to buy) | |
| Immunome Inc | Sandra M. Swain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 11,333 | 11,333 | - | - | Stock option (right to buy) | |
| Immunome Inc | Sandra M. Swain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2024 | 25,737 | 25,737 | - | - | Stock option (right to buy) | |
| Seagen Inc | Sandra M. Swain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 2,044 | 2,822 (0%) | 0% | 0 | Common Stock | |
| Seagen Inc | Sandra M. Swain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2022 | 1,763 | 1,763 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Seagen Inc | Sandra M. Swain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2022 | 778 | 778 (0%) | 0% | 0 | Common Stock |